Ragon Institute of MGH, MIT and Harvard   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Boston MA United States (2009)

Organization Overview

First Clinical Trial
2010
NCT01215149
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ragon Institute | Ragon Institute of MGH, MIT and Harvard